H

Hwail Pharm Co Ltd
KOSDAQ:061250

Watchlist Manager
Hwail Pharm Co Ltd
KOSDAQ:061250
Watchlist
Price: 1 158 KRW -0.26% Market Closed
Market Cap: 100.2B KRW

Intrinsic Value

The intrinsic value of one Hwail Pharm Co Ltd stock under the Base Case scenario is hidden KRW. Compared to the current market price of 1 158 KRW, Hwail Pharm Co Ltd is hidden .

The Intrinsic Value is calculated as the average of DCF and Relative values:

Hwail Pharm Co Ltd Intrinsic Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation History
Hwail Pharm Co Ltd

Intrinsic Value History
Dive into the past to invest in the future

Hwail Pharm Co Ltd looks undervalued. But is it really? Some stocks live permanently below intrinsic value; one glance at Historical Valuation reveals if Hwail Pharm Co Ltd is one of them.

Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Show Historical Valuation
What is Valuation History?
Ask AI Assistant
What other research platforms think about Hwail Pharm Co Ltd?

Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.

Discover External Valuations
Why is Hwail Pharm Co Ltd valued this way?

Let our AI break down the key assumptions behind the intrinsic value calculation for Hwail Pharm Co Ltd.

Explain Valuation
Compare Hwail Pharm Co Ltd to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about Hwail Pharm Co Ltd?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Hwail Pharm Co Ltd

Current Assets 131.3B
Cash & Short-Term Investments 71.4B
Receivables 30B
Other Current Assets 29.8B
Non-Current Assets 85.4B
Long-Term Investments 17B
PP&E 66.5B
Intangibles 1.8B
Other Non-Current Assets 41.5m
Current Liabilities 7.3B
Accounts Payable 3.9B
Accrued Liabilities 774.2m
Other Current Liabilities 2.7B
Non-Current Liabilities 617.5m
Long-Term Debt 236.1m
Other Non-Current Liabilities 381.4m
Efficiency

Free Cash Flow Analysis
Hwail Pharm Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Hwail Pharm Co Ltd

Revenue
114.2B KRW
Cost of Revenue
-105.2B KRW
Gross Profit
9B KRW
Operating Expenses
-10.2B KRW
Operating Income
-1.2B KRW
Other Expenses
6.9B KRW
Net Income
5.8B KRW
Fundamental Scores

Profitability Score
Profitability Due Diligence

Hwail Pharm Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Net Margin is Increasing
Low 3Y Average Gross Margin
Declining Gross Margin
Declining ROIC
hidden
Profitability
Score

Hwail Pharm Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Hwail Pharm Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Negative Net Debt
hidden
Solvency
Score

Hwail Pharm Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Hwail Pharm Co Ltd

There are no price targets for Hwail Pharm Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Hwail Pharm Co Ltd is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
Lowest
Average
Highest
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y
What is the Intrinsic Value of one Hwail Pharm Co Ltd stock?

The intrinsic value of one Hwail Pharm Co Ltd stock under the Base Case scenario is hidden KRW.

Is Hwail Pharm Co Ltd stock undervalued or overvalued?

Compared to the current market price of 1 158 KRW, Hwail Pharm Co Ltd is hidden .

Back to Top